9.1 Informed Consent, Treatment Refusal, & Autonomy in Wound Care

Informed Consent, Treatment Refusal, & Autonomy in Wound Care

Informed consent and treatment refusal are foundational legal and bioethical constructs governing clinical wound management. Certified Wound Care Specialists (WCC) frequently perform interventions that carry inherent physical risks, including conservative sharp debridement (CSD), chemical or surgical cauterization, application of advanced biologic dressings, and chemical debridement agents. To honor patient autonomy and uphold professional legal standards, clinicians must ensure that consent is obtained systematically rather than treated as a routine bureaucratic formality. Furthermore, when patients exercise their autonomous right to decline recommended wound therapies, clinicians must navigate the complex legal requirements of informed refusal documentation.

---

Essential Legal Elements of Valid Informed Consent

For consent to be legally valid and ethically sound, it must be voluntary, informed, and granted by an individual with decision-making capacity. In wound care practice, five mandatory legal components must be communicated and understood prior to initiating invasive interventions:

1. Nature and Purpose of the Procedure: A clear, jargon-free explanation of the intervention (e.g., "Using a sterile scalpel and curette to trim away dead, infected tissue from the ulcer bed to promote fresh tissue growth").
2. Expected Benefits: The specific therapeutic goals anticipated from the treatment (e.g., reduction of bacterial bioburden, acceleration of autolytic healing, control of malodor).
3. Material Risks and Potential Complications: Full disclosure of common and severe risks associated with the procedure, including bleeding, local tissue trauma, pain, transient bacteremia, damage to underlying structures (tendons, nerves, blood vessels), and potential need for secondary surgical intervention.
4. Reasonable Treatment Alternatives: Explanation of alternative therapeutic options, including non-invasive or conservative modalities (e.g., enzymatic debridement gels, autolytic dressings, mechanical hydro-surgery) and the specific risks and benefits of each alternative.
5. Risks of Refusing Treatment / Non-Treatment: Explicit discussion of the natural trajectory of the wound if no intervention is performed, including risk of progressive necrosis, cellulitis, osteomyelitis, systemic sepsis, limb amputation, or death.
6. Practitioner Identity and Credentials: Clear disclosure of the licensure, role, and qualifications of the clinician performing the procedure (e.g., Registered Nurse Certified in Wound Care, Physical Therapist, Nurse Practitioner).

Express vs. Implied Consent in Clinical Practice

• Implied Consent: Inferred through a patient's voluntary actions during routine, low-risk, non-invasive procedures (e.g., a patient extending their lower leg and allowing the clinician to remove a secondary bandage or cleanse an intact skin margin).
• Express Consent: Explicit verbal or written authorization mandated for invasive or higher-risk wound interventions. Written express consent—documented on a formal institutional consent form signed by the patient or legal surrogate—is standard of care prior to sharp debridement, sharp biopsy, application of cellular and tissue-based products (CTPs), or initiation of negative pressure wound therapy (NPWT) in complex anatomical locations.

---

Assessment of Clinical Decision-Making Capacity vs. Legal Competence

A critical duty of the wound care clinician is differentiating between clinical decision-making capacity and legal competence when obtaining consent or managing treatment refusal.

Clinical Capacity Assessment Protocol (The CURVES Framework)

To verify that a patient possesses decision-making capacity to consent to or refuse a wound care intervention, the clinician must assess four functional cognitive criteria:

• Communication: Can the patient clearly communicate their choice choices consistently?
• Understanding: Does the patient understand the nature of their wound, the proposed treatment, and the associated risks?
• Appreciation: Does the patient appreciate how the information applies to their personal health situation (e.g., acknowledging that an unmanaged diabetic foot ulcer could lead to osteomyelitis)?
• Reasoning: Can the patient process the logical consequences of various options and articulate a rational explanation for their choice?

If a patient lacks capacity due to acute encephalopathy, advanced dementia, or severe delirium, consent or refusal authority automatically transfers to the designated Durable Power of Attorney for Healthcare (DPOAHC) or legal court-appointed guardian.

---

Managing and Documenting Informed Refusal (Against Medical Advice / AMA)

Adult patients with verified decision-making capacity possess an absolute legal right to decline any medical or nursing intervention, including life-saving therapies or essential wound treatments (e.g., refusing compression therapy for venous leg ulcers or refusing offloading boots for heel pressure injuries). A refusal of care does not constitute client abandonment by the clinician, provided the refusal is managed and documented meticulously.

Required Components of Informed Refusal Charting

When a patient declines a recommended wound intervention, the medical record must contain a comprehensive, non-judgmental narrative documenting:

1. Capacity Verification: Explicit notes demonstrating that the patient possessed decision-making capacity during the discussion.
2. Detailed Disclosure: Specific documentation of the exact risks discussed, including extreme outcomes (e.g., "Explained to patient that refusing sharp debridement of necrotic heel tissue creates a high risk of deep tissue infection, osteomyelitis, systemic sepsis, and leg amputation").
3. Patient Rationale: Direct quotes or objective summary of the patient's stated reasons for refusal (e.g., pain concerns, financial constraints, personal end-of-life philosophy).
4. Offered Alternative Plan: Documentation of less invasive or alternative harm-reduction care plans offered and accepted (e.g., applying enzymatic gel debridement when sharp debridement is declined).
5. Attending Provider & Team Notification: Timely communication of the refusal to the primary physician, attending team, and interprofessional wound care panel.
6. Witness & Patient Signatures: Obtaining signed formal refusal / AMA documentation signed by the patient (or surrogate) and an independent clinical witness.